Page 54 - 2019食藥署年報(英文版)
P. 54

LGHQWL¿FDWLRQ  GDWD LQWHJULW\ HWF  7KLV HYHQW DOVR SURYLGH D SODWIRUP IRU SDUWLFLSDQWV WR H[FKDQJH
                  information, share experience, revised related guidance documents and map out future plans for
                  inspector training.

                     $POEVDUFE  UIF TJYUI +PJOU $POGFSFODF PG 5BJXBO BOE +BQBO PO .FEJDBM

                     1SPEVDUT 3FHVMBUJPO

                            th
                       "The 6  Joint Conference of Taiwan and Japan on Medical Products Regulation" was held
                  in Tokyo on October 11, 2018. Other than TFDA, National Health Insurance Administration of
                  Ministry of Health and Welfare, Center for Drug Evaluation, the representatives of the industries

                  and pharmaceutical and medical device related industry and associations also attended the
                  conference in Japan. The representatives from the official authorities and industries of both
                  countries gave speeches on topics ranging from the development and trend of drug regulations,
                  the practical management of Real-World Data, promotion policy of OTC, the management model
                  for the 3D printing of medical devices and the international regulatory harmonization strategies.


                  0VUDPNFT BOE #FOFGJUTVUDPNFT BOE #FOFGJUT
                  0

                     .BKPS CSFBLUISPVHI JO UIF JOUFSOBUJPOBM NFEJDBM DPPQFSBUJPO

                       Becoming an ICH member is a major achievement of Taiwan’s efforts on stipulating
                  international drug management regulations in the past few years, and it is also best proof that
                  Taiwan’s drug management regulations meet the international standards. TFDA has continued to
                  expand its participation in ICH related activities
                  (Figure 3-3). So far, more than 30 experts have
                  been selected to participate in more than 20 expert
                  working groups in the development of guidelines,

                  and vigorously contributed their strength. At
                  the same time, a working group of industry,
                  government and academia was formed in Taiwan   'JHVSF    cc" HSPVQ QIPUP PG      *$)
                  to understand the actual needs of industrial                     FWFOU QBSUJDJQBOUT
                  upgrading, and handled the guidance training and actively implements ICH guidelines, so that
                  ICH guidelines can be implemented in Taiwan’s pharmaceutical industry earlier and more
                  effectively.


                      5IF      "1&$ XPSLTIPQ XBT IJHIMZ SFDPHOJ[FE

                       A total of 62 trainees from 14 APEC member economies participated in the seminar, and
                  the overall satisfaction score of the trainees was 4.35 (out of 5). All the participating economies
                  valued the importance of Good Registration Management (GRM). After the workshop, many
                  representatives from different economies consulted TFDA for the assistance of providing
            52
   49   50   51   52   53   54   55   56   57   58   59